Y-Intercept (HK)’s Evommune Inc EVMN Stock Holding History

Y-Intercept (HK)’s Portfolio EVMN Stock Details EVMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.31M	Buy	158,813 +130,415	+459%	+$1.56M	0.03%	863
2026 Q2	$377K	Buy	+28,398	New	+$660K	0.01%	1397

Other funds holding EVMN

Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Y-Intercept (HK)'s EVMN Position: Q3 2026 in Review

Y-Intercept (HK) increased its Evommune Inc (EVMN) stake by 459% in Q3 2026, buying an estimated $1.56M and bringing the position to 158,813 shares worth $1.31M. The position accounts for 0.03% of the portfolio, ranked #863.

Y-Intercept (HK) first reported a position in EVMN in Q2 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold EVMN as of Q3 2026.

Y-Intercept (HK) held 158,813 shares of Evommune Inc worth $1.31M as of Q3 2026.
Y-Intercept (HK) bought 130,415 Evommune Inc shares in Q3 2026, an estimated $1.56M.
Evommune Inc made up 0.03% of Y-Intercept (HK)'s portfolio in Q3 2026, its #863 holding.
Y-Intercept (HK) first reported a position in Evommune Inc in Q2 2026 and has held it in 2 quarters since.
8 funds tracked by Wall St. Rank held Evommune Inc as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.